Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Fresenius Kabi AB Brunna aggregated by PharmaCompass.com.

    Client Virtual Booth

    FRESENIUS KABI AB BRUNNA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Fresenius Kabi AB Brunna
    Sweden Flag
    Country
    Country
    Sweden
    Address
    Address
    North Stockholm, Brunna
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cmo.fresenius-kabi.com/brunna-sweden
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Fresenius Kabi USA Generic Naloxone Hydrochloride Receives Approval in the U.S.
    Fresenius Kabi USA Generic Naloxone Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213573

    FDA
    02 Apr 2024
    Share Share
    Fresenius Kabi's Tyenne (tocilizumab) Receives Approval in Europe
    Fresenius Kabi's Tyenne (tocilizumab) Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/tyenne-epar-medicine-overview_en.pdf

    EMA
    02 Oct 2023
    Share Share
    Fresenius Kabi's Biologic Chorionic Gonadotropin Receives Approval in the U.S.
    Fresenius Kabi's Biologic Chorionic Gonadotropin Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017067

    FDA
    02 Oct 2023
    Share Share
    Metrodora Institute, Chooses the Ivenix Infusion System from Fresenius Kabi
    Metrodora Institute, Chooses the Ivenix Infusion System from Fresenius Kabi

    https://www.businesswire.com/news/home/20230629552234/en

    BUSINESSWIRE
    29 Jun 2023
    Share Share
    Fresenius Kabi Launches Single-Needle Option for the Amicus®
    Fresenius Kabi Launches Single-Needle Option for the Amicus®

    https://www.businesswire.com/news/home/20230423005002/en

    BUSINESSWIRE
    24 Apr 2023
    Share Share
    Vizient Innovative Technology Contract Awarded to Fresenius Kabi for the Ivenix
    Vizient Innovative Technology Contract Awarded to Fresenius Kabi for the Ivenix

    https://www.businesswire.com/news/home/20230417005362/en

    BUSINESSWIRE
    17 Apr 2023
    Share Share
    Enforcement Report - Week of January 25, 2023
    Enforcement Report - Week of January 25, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf

    FDA
    25 Jan 2023
    Share Share
    Fresenius Kabi Deutschland's Biologic Stimufend (pegfilgrastim) Receives Approval in Europe
    Fresenius Kabi Deutschland's Biologic Stimufend (pegfilgrastim) Receives Approval in Europe

    https://www.ema.europa.eu/en/medicines/human/EPAR/stimufend

    EMA
    04 Apr 2022
    Share Share
    Health Canada Issues Recall of Fresenius Kabi Canada Sodium Acetate Injection, USP: Particulate matter
    Health Canada Issues Recall of Fresenius Kabi Canada Sodium Acetate Injection, USP: Particulate matter

    https://recalls-rappels.canada.ca/en/alert-recall/sodium-acetate-injection-usp-particulate-matter

    HEALTH CANADA
    09 Mar 2022
    Share Share
    Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP Due to the Presence of Particulate Matter
    Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP Due to the Presence of Particulate Matter

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-recall-sodium-acetate-injection-usp-due-presence-particulate-matter

    FDA
    07 Mar 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search